Credo

Credo is a health care startup empowering providers to excel in value-based care through its innovative medical record retrieval and analysis platform. Recognizing the challenges posed by the overwhelming amount of faxed medical information among providers, Credo aims to streamline this process and provide crucial patient medical histories in a more efficient manner. With a focus on aiding value-based care organizations, the platform is designed to gather and summarize essential information, enabling providers to deliver exceptional care, accurately risk-adjust, and achieve superior reimbursement outcomes. Founded in 2021, Credo's cutting-edge solution has garnered significant attention in the industry. In January 2024, the company secured a noteworthy $5.25M seed round investment from prominent investors including SpringTime Ventures, FCA Venture Partners, FirstMile Ventures, and Hannah Grey Ventures. This injection of capital signals confidence in Credo's potential to make a lasting impact in the health care sector. As the company continues to expand its reach, Credo is committed to driving forward its vision of digitizing healthcare. With a pilot program underway for select patient populations, the company seeks to forge strategic partnerships to further its mission. Those interested in participating in this initiative are encouraged to engage with Credo. Overall, Credo is poised to revolutionize value-based care and significantly improve the healthcare landscape. For additional information and partnership opportunities, interested parties can visit www.credohealth.com.